Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091
20101
20112
20151
20162
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Royal Wolverhampton Hospitals NHS Trust2
AstraZeneca1
Baim Institute for Clinical Research1
Eli Lilly and Company1
Imperial College London1
NHS Greater Glasgow and Clyde1
NHS National Waiting Times Centre Board1
Ole Frobert, MD, PhD1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sheffield Teaching Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction12
Acute Coronary Syndrome2
Non-ST Elevated Myocardial Infarction2
ST Elevation Myocardial Infarction2
Stroke2
Angina, Unstable1
Cardiovascular Diseases1
Coronary Artery Disease1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.